EyePoint Pharmaceuticals ... (EYPT)
NASDAQ: EYPT
· Real-Time Price · USD
11.09
0.24 (2.21%)
At close: Aug 15, 2025, 3:59 PM
11.09
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT
EyePoint Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 51.9M | 56.04M | 43.27M | 45.71M | 50.39M | 50.02M | 46.02M | 42.52M | 37.33M | 39.79M | 41.4M | 42.41M | 41.46M | 38.91M | 36.94M | 32.53M | 39.16M | 34.27M |
Cost of Revenue | 2.52M | 3.76M | 3.71M | 3.89M | 4.36M | 4.75M | 4.63M | 7.04M | 7.25M | 7.19M | 8.33M | 7.95M | 8.37M | 8.56M | 8.18M | 7.61M | 7.66M | 6.24M |
Gross Profit | 49.38M | 52.28M | 39.56M | 41.82M | 46.03M | 45.27M | 41.39M | 35.48M | 30.09M | 32.6M | 33.08M | 34.47M | 33.09M | 30.35M | 28.76M | 24.92M | 31.5M | 28.04M |
Operating Income | -189.05M | -161.37M | -145.85M | -116.97M | -98.62M | -86.83M | -75.07M | -81.75M | -85.75M | -82.2M | -78.93M | -73.95M | -70.86M | -62.63M | -55.28M | -49.96M | -36.61M | -36.78M |
Interest Income | 13.87M | 14.69M | 15.09M | 13.48M | 11.88M | 9.78M | 6.95M | 5.67M | 4.53M | 3.27M | 2.13M | 1.07M | 435K | 353K | 293K | 287K | 281K | 9K |
Pretax Income | -175.29M | -146.69M | -130.78M | -103.49M | -86.74M | -78.83M | -70.71M | -100.15M | -105.96M | -102.44M | -102.25M | -78.23M | -76.51M | -67.11M | -58.42M | -54.45M | -41.56M | -44.5M |
Net Income | -175.38M | -146.78M | -130.87M | -103.57M | -86.82M | -78.92M | -71.22M | -121.27M | -127.1M | -123.58M | -124.53M | -79.81M | -78.07M | -68.67M | -58.42M | -54.45M | -41.56M | -44.5M |
Selling & General & Admin | 51.44M | 52.34M | 52.54M | 51.33M | 49.38M | 50.92M | 51.79M | 54.77M | 58.96M | 60.06M | 60.32M | 62.94M | 61.14M | 57.55M | 53.08M | 47.64M | 45.27M | 44.31M |
Research & Development | 186.99M | 161.31M | 132.88M | 107.45M | 95.28M | 81.18M | 64.66M | 62.25M | 56.05M | 53.31M | 49.64M | 43.02M | 40.35M | 32.97M | 28.5M | 24.79M | 20.38M | 18.05M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 205K | 820K | 1.44M | 2.05M | 2.46M | 2.46M | 2.46M | 2.46M | 2.46M | 2.46M | 2.46M |
Operating Expenses | 238.43M | 213.65M | 185.41M | 158.79M | 144.65M | 132.1M | 116.45M | 117.23M | 115.83M | 114.81M | 112.01M | 108.41M | 103.96M | 92.97M | 84.04M | 74.89M | 68.11M | 64.82M |
Interest Expense | 14K | 14K | 14K | n/a | n/a | 435K | 1.25M | 2.03M | 2.69M | 2.81M | 3.19M | 3.8M | 4.52M | 5.35M | 5.5M | 5.94M | 6.39M | 6.82M |
Selling & Marketing Expenses | 110K | 160K | 131K | 265K | 720K | 5.96M | 11.69M | 17.42M | 22.96M | 24.55M | 25.51M | 27.4M | 28.76M | 28.54M | 27.5M | 25.5M | 23.4M | 22.83M |
Cost & Expenses | 240.95M | 217.41M | 189.13M | 162.68M | 149.01M | 136.85M | 121.08M | 124.27M | 123.08M | 122M | 120.34M | 116.36M | 112.33M | 101.54M | 92.22M | 82.49M | 75.77M | 71.05M |
Income Tax Expense | 90K | 90K | 90K | 83K | 83K | 83K | 505K | 21.12M | 21.14M | 21.14M | 22.28M | 1.58M | 1.56M | 1.56M | 6K | 6K | n/a | 8K |
Shares Outstanding (Basic) | 69.93M | 69.77M | 64.56M | 54.45M | 53.21M | 52.91M | 42.17M | 38.34M | 37.58M | 37.49M | 37.35M | 37.34M | 37.32M | 37.25M | 32.7M | 28.77M | 28.6M | 24.73M |
Shares Outstanding (Diluted) | 69.93M | 69.77M | 64.56M | 54.45M | 53.21M | 52.91M | 42.17M | 38.34M | 37.58M | 37.49M | 37.35M | 37.34M | 37.32M | 37.25M | 32.7M | 28.77M | 28.74M | 24.73M |
EPS (Basic) | -2.68 | -2.41 | -2.31 | -2 | -1.79 | -1.82 | -1.85 | -3.24 | -3.4 | -3.31 | -3.33 | -2.2 | -2.29 | -2.12 | -2.02 | -2.5 | -2.22 | -2.91 |
EPS (Diluted) | -2.68 | -2.41 | -2.31 | -2 | -1.79 | -1.82 | -1.85 | -3.24 | -3.4 | -3.31 | -3.33 | -2.2 | -2.29 | -2.12 | -2.02 | -2.5 | -2.22 | -2.91 |
EBITDA | -177.45M | -148.59M | -129.23M | -102.3M | -85.85M | -77.73M | -69M | -97.43M | -101.98M | -97.78M | -96.62M | -71.63M | -69.27M | -59.07M | -50.23M | -45.86M | -32.46M | -34.99M |
EBIT | -178.83M | -150.32M | -130.77M | -103.49M | -86.74M | -78.4M | -69.47M | -98.12M | -103.27M | -99.64M | -99.06M | -74.44M | -71.99M | -61.77M | -52.92M | -48.52M | -35.17M | -37.68M |
Depreciation & Amortization | 1.37M | 1.73M | 1.54M | 1.19M | 892K | 662K | 464K | 687K | 1.28M | 1.85M | 2.45M | 2.81M | 2.71M | 2.69M | 2.69M | 2.66M | 2.7M | 2.69M |